Indeed, the IBI315‐treated tumor exhibited the highest infiltration of CD3+, CD8+, and CD4+ lymphocytes compared to the control group, parental mAbs groups, or the parental two‐drug combination group in both N87 tumor model and PDX‐1 model (Figure 2D,E and Figure S7, Supporting Information). The gene discussed is CD4; the disease is neoplasm.